Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
CODA Biotherapeutics
company
About
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $670K
- Industries
- Biotechnology,Genetics,Medical,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$62.67M
CODA Biotherapeutics has raised a total of
$62.67M
in funding over 2 rounds. Their latest funding was raised on
Dec 2, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 2, 2021 | Series Unknown | $28M | 1 | — | — | Detail |
| Nov 10, 2020 | Grant | $670K | 1 | — | — | Detail |
| Nov 5, 2019 | Series A | $15M | 1 |
Versant Ventures
|
— | Detail |
| Sep 12, 2018 | Series A | $19M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
CODA Biotherapeutics is funded by 2 investors.
Versant Ventures
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
— | Series Unknown |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
